How RWD and technology can help the life sciences industry re-invent clinical development
28 February, 2020
The rise of fake news could be making disease outbreaks worse – according to new research from the University of East Anglia (UEA).
14 February, 2020
Experts in the emotional needs of small children say increased levels of the stress hormone cortisol in babies and small children who are separated from their parents, especially their mothers, could have a long-term genetic impact on future generations. In a commentary published by the Journal of the Royal Society of Medicine, the authors say that several studies show that small children cared for outside the home, especially in poor quality care and for 30 or more hours per week, have higher levels of cortisol than children at home.
14 February, 2020
Glasshouse, Alderley Park’s new hub for tech companies and forward thinking, innovative businesses has officially opened.
13 February, 2020
Every nine seconds, there is a new cancer case diagnosed in the EU and it is currently the second leading cause of death following cardiovascular disease. In addition to the considerable impact on the lives of European citizens, cancer puts a huge strain on Europe’s health and social systems as well as the economy.
13 February, 2020
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development
12 February, 2020
Causes of cancer are being catalogued by a huge international study revealing the genetic fingerprints of DNA-damaging processes that drive cancer development. Researchers from the Wellcome Sanger Institute, Duke-NUS Medical School Singapore, University of California San Diego School of Medicine, the Broad Institute of MIT and Harvard, and their collaborators around the world have achieved the most detailed list of these genetic fingerprints to date, providing clues as to how each cancer developed.
05 February, 2020
NASA’s Translational Research Institute for Space Health (TRISH) has funded innovative projects seeking to better protect astronauts' health during deep space missions of three years or more. Two of the six projects focus on ‘just-in-time’ medications, which allow drugs to be manufactured on-demand and on-board the spacecraft – a necessity given that most commercially available medicines have shelf lives of two years or less.
01 February, 2020